Article
APOE modulates the effect of estrogen therapy on Aβ accumulation EFAD-Tg mice.
Neuroscience letters - 7 Feb 2014
Kunzler Jacqueline, Youmans Katherine L, Yu Chunjiang, Ladu Mary Jo, Tai Leon M
Abstract excerpt
The post-menopausal loss of estrogen is key in the increased incidence of Alzheimer's disease (AD) in women. However, estrogen therapy (ET) clinical trials have produced conflicting results. The APOE gene of apolipoprotein E (apoE) likely modulates the effects of ET in AD. APOE4 is the greatest genetic risk factor for AD, increasing risk up to 15-fold compared with APOE3, and the negative effect of APOE4 on AD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
